Serrumab: A human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom

Journal of Immunotoxicology

Volumn 9, Issue 2, 2012, Pages 173-183

  Pucca, Manuela Berto ^a   Zoccal, Karina Furlan ^a   Roncolato, Eduardo Crosara ^a   Bertolini, Thaís Barboza ^a   Campos, Lucas Benício ^a   Cologna, Camila Takeno ^a   Faccioli, Lúcia Helena ^a   Arantes, Eliane Candiani ^a   Barbosa, José Elpidio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti venom; Antibodies; Cytokines; Monoclonal; Phage display; Scorpion venoms; Single chain antibodies

Indexed keywords

ANTIBODY; ASPARTATE AMINOTRANSFERASE; CREATININE; CYTOKINE; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 6; MONOCLONAL ANTIBODY; SERRUMAB; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY 2A; TITYUS TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTHROPOD; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIOPHAGE; BLOOD SAMPLING; CELL LINE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; GLUCOSE BLOOD LEVEL; GROWTH INHIBITION; IMMUNOASSAY; IMMUNOGENICITY; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PERITONEUM MACROPHAGE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN PURIFICATION; TITYUS SERRULATUS; UREA BLOOD LEVEL;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVENINS; CELL SURVIVAL; CYTOKINES; INSECT PROTEINS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; SCORPION VENOMS; SCORPIONS; SINGLE-CHAIN ANTIBODIES;

MURINAE; MUS; SCORPIONES; TITYUS SERRULATUS;

EID: 84861076951     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2011.649220     Document Type: Article

References (68)

1. Alvarenga, L. M., Diniz, C. R., Granier, C., and Chávez- Olórtegui, C. 2002. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes. Toxicon. 40:89-95.
2. Alvarenga, L. M., Martins, M. S., Moura, J. F., Kalapothakis, E., Oliveira, J. C., Mangili, O. C., Granier, C., and Chávez- Olórtegui, C. 2003. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay. Toxicon. 42:725-731.
3. Amaral, C. F., Barbosa, A. J., Leite, V. H., Tafuri, W. L., and de Rezende, N. A. 1994. Scorpion sting-induced pulmonary edema: Evidence of increased alveolocapillary membrane permeability. Toxicon. 32:999-1003.
4. Amaral, C. F., de Rezende, N. A., and Freire-Maia, L. 1993. Acute pulmonary edema after Tityus serrulatus scorpion sting in children. Am J Cardiol. 71:242-245.
5. Amaro, I., Riano-Umbarila, L., Becerril, B., and Possani, L. D. 2011. Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion. Immunol Lett. 139:73-79.
6. Bertazzi, D. T., de Assis-Pandochi, A. I., Talhaferro, V. L., Caleiro Seixas Azzolini, A. E., Pereira Crott, L. S., and Arantes, E. C. 2005. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom. Int Immunopharmacol. 5:1077-1084.
7. Billiald, P., Motta, G., and Vaux, D. J. 1995. Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli. Arch Biochem Biophys. 317:429-438.
8. Bucaretchi, F., Baracat, E. C., Nogueira, R. J., Chaves, A., Zambrone, F. A., Fonseca, M. R., and Tourinho, F. S. 1995. A comparative study of severe scorpion envenomation in children caused by Tityus bahiensis and Tityus serrulatus. Rev Inst Med Trop Sao Paulo. 37:331-336.
9. Campos, J. A., Silva, O. A., Lopes, M., and Freire-Maia, L. 1980. Signs, symptoms and treatment of severe scorpion poisoning in children. In: Natural Toxins (Press, P., Ed.). Oxford: Pergamon Press, pp. 61-68.
10. Carter, P., Bedouelle, H., and Winter, G. 1985. Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res. 13:4431-4443.
11. Cestèle, S., and Catterall, W. A. 2000. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie. 82:883-892.
12. Chavez-Olortegui, C., Molina, F., and Granier, C. 2002. Molecular basis for the cross-reactivity of antibodies elicited by a natural anatoxin with a-And β-Toxins from the venom of Tityus serrulatus scorpion. Mol Immunol. 38:867-876.
13. Cologna, C. T., Marcussi, S., Giglio, J. R., Soares, A. M., and Arantes, E. C. 2009. Tityus serrulatus scorpion venom and toxins: An overview. Protein Pept Lett. 16:920-932.
14. Corrêa, M. M., Sampaio, S. V., Lopes, R. A., Mancuso, L. C., Cunha, O. A., Franco, J. J., and Giglio, J. R. 1997. Biochemical and histopathological alterations induced in rats by Tityus serrulatus scorpion venom and its major neurotoxin tityustoxin-I. Toxicon. 35:1053-1067.
15. Cupo, P., and Hering, S. E. 2002. Cardiac troponin I release after severe scorpion envenoming by Tityus serrulatus. Toxicon. 40:823-830.
16. Cupo, P., Jurca, M., Azeedo-Marques, M. M., Oliveira, J. S., and Hering, S. E. 1994. Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects. Rev Inst Med Trop Sao Paulo. 36:67-76.
17. de Sousa Alves, R., do Nascimento, N. R., Barbosa, P. S., Kerntopf, M. R., Lessa, L. M., de Sousa, C. M., Martins, R. D., Sousa, D. F., de Queiroz, M. G., Toyama, M. H., Fonteles, M. C., Martins, A. M., and Monteiro, H. S. 2005. Renal effects and vascular reactivity induced by Tityus serrulatus venom. Toxicon. 46:271-276.
18. Devaux, C., Moreau, E., Goyffon, M., Rochat, H., and Billiald, P. 2001. Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. Eur J Biochem. 268:694-702.
19. Diniz, C. R. 1978. Chemical and pharmacologic aspects of Titynae venoms. In: Arthropod Venoms (Bettini, S., Ed.). Berlin: Springer, pp. 317-369.
20. Duarte, C. G., Alvarenga, L. M., Dias-Lopes, C., Machado-de-Avila, R. A., Nguyen, C., Molina, F., Granier, C., and Chávez-Olórtegui, C. 2010. In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope. Vaccine. 28:1168-1176.
21. Eklund, K. K., Humphries, D. E., Xia, Z., Ghildyal, N., Friend, D. S., Gross, V., and Stevens, R. L. 1997. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-Alpha, and the IL-10-induced expression of chymases. J Immunol. 158:4373-4380.
22. Freire-Maia, L., and Campos, J. A., 1989. Pathophysiology and treatment of scorpion poisoning. In: Natural Toxins (Press, P., Ed.). Oxford: Pergamon Press, pp. 139-159.
23. Fukuhara, Y. D., Reis, M. L., Dellalibera-Joviliano, R., Cunha, F. Q., and Donadi, E. A. 2003. Increased plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-A in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon. 41:49-55.
24. Gazarian, K. G., Gazarian, T., Hernández, R., and Possani, L. D. 2005. Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines. Vaccine. 23: 3357-3368.
25. George, A., Huston, J. S., and Haber, E. 1996. Exploring and exploiting the antibody and Ig superfamily combining sites. Nat Biotechnol. 14:584.
26. Gibson, T. J. 1984. Studies on the Epstein-Barr Virus Genome. Ph.D. thesis, University of Cambridge
27. Green, S., and Springer, J. A. 1973. The dominant-lethal test: Potential limitations and statistical considerations for safety evaluation. Environ Health Perspect. 6:37-46.
28. Isaacs, J. D. 1990. The anti-globulin response to therapeutic antibodies. Semin Immunol. 2:449-456.
29. Juárez-González, V. R., Riano-Umbarila, L., Quintero-Hernández, V., Olamendi-Portugal, T., Ortiz-León, M., Ortíz, E., Possani, L. D., and Becerril, B. 2005. Directed evolution, phage display and combination of evolved mutants: A strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2. J Mol Biol. 346:1287-1297.
30. Lorimer, I. A., Keppler-Hafkemeyer, A., Beers, R. A., Pegram, C. N., Bigner, D. D., and Pastan, I. 1996. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: Targeting with a single chain antibody variable domain isolated by phage display. Proc Natl Acad Sci USA. 93:14815-14820.
31. Lorke, D. 1983. A new approach to practical acute toxicity testing. Arch Toxicol. 54:275-287.
32. Lovrecek, D., and Tomic, S. 2011. A century of anti-venom. Coll Antropol. 35:249-258.
33. Lowe, R. M., and Farrell, P. M. 2011. A portable device for the electrical extraction of scorpion venom. Toxicon. 57:244-247.
34. Lutz, A., and Mello, O. 1992. Description of five Brazilian species of the genus Tityus and Rhopalurus. Folha Médica. 4:25-26.
35. Marangoni, S., Ghiso, J., Sampaio, S. V., Arantes, E. C., Giglio, J. R., Oliveira, B., and Frangione, B. 1990. The complete amino acid sequence of toxin TsTX-VI isolated from the venom of the scorpion Tityus serrulatus. J Protein Chem. 9:595-601.
36. Marks, J. D., Griffiths, A. D., Malmqvist, M., Clackson, T. P., Bye, J. M., and Winter, G. 1992. By-passing immunization: Building high affinity human antibodies by chain shuffling. Biotechnology (NY). 10:779-783.
37. Meddeb-Mouelhi, F., Bouhaouala-Zahar, B., Benlasfar, Z., Hammadi, M., Mejri, T., Moslah, M., Karoui, H., Khorchani, T., and El Ayeb, M. 2003. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Toxicon. 42:785-791.
38. Ministerio-da-Saude. 2011. Acidentes por animais peçonhentos -Escorpioes. Aspectos edpidemiológicos. Available online at: Http://portal.saude.gov.br/portal/saude/profissional/area. cfm?id-area=1537, accessed 3 July 2011.
39. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55-63.
40. Mossalayi, M. D., Paul-Eugne, N., Ouaaz, F., Arock, M., Kolb, J. P., Kilchherr, E., Debr, P., and Dugas, B. 1994. Involvement of Fce RII/CD23 and L-Arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions. Int Immunol. 6:931-934.
41. Mousli, M., Devaux, C., Rochat, H., Goyffon, M., and Billiald, P. 1999. A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector. FEBS Lett. 442:183-188.
42. Medical-Research-Council, 2009. Available online at: Http://www.mrc-cpe. cam. ac.uk/, accessed 15 February 2010.
43. Nishikawa, A. K., Caricati, C. P., Lima, M. L., Dos Santos, M. C., Kipnis, T. L., Eickstedt, V. R., Knysak, I., Da Silva, M. H., Higashi, H. G., and Da Silva, W. D. 1994. Antigenic cross-reactivity among the venoms from several species of Brazilian scorpions. Toxicon. 32:989-998.
44. Oliveira, J. G., Soares, S. G., Soares, A. M., Giglio, J. R., Teixeira, J. E., and Barbosa, J. E. 2009. Expression of human recombinant antibody fragments capable of partially inhibiting the phospholypase activity of Crotalus durissus terrificus venom. Basic Clin Pharmacol Toxicol. 105:84-91.
45. Ozkan, O., Adiguzel, S., Inceoglu, B., Lango, J., Ertek, M., and Hammock, B. D. 2008. Evaluation of the neutralizing capacity of Androctonus crassicauda (Olivier, 1807) anti-venom against Leiurus quinquestriatus (Ehrenberg, 1928) venom (Scorpiones: Buthidae). J. Venomous Anim. Toxins Trop. Dis. 14:481-496.
46. Pessini, A. C., de Souza, A. M., Faccioli, L. H., Gregório, Z. M., and Arantes, E. C. 2003. Time course of acute-phase response induced by Tityus serrulatus venom and TsTX-I in mice. Int Immunopharmacol. 3:765-774.
47. Petricevich, V. L., and Lebrun, I. 2005. Immunomodulatory effects of the Tityus serrulatus venom on murine macrophage functions in vitro. Mediators Inflamm. 2005:39-49.
48. Pimenta, A. M., De Marco Almeida, F., de Lima, M. E., Martin-Eauclaire, M. F., and Bougis, P. E. 2003. Individual variability in Tityus serrulatus (Scorpiones, Buthidae) venom elicited by matrix-Assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 17:413-418.
49. Pimenta, A. M., Martin-Eauclaire, M., Rochat, H., Figueiredo, S. G., Kalapothakis, E., Afonso, L. C., and De Lima, M. E. 2001. Purification, amino-Acid sequence and partial characterization of two toxins with anti-insect activity from the venom of the South American scorpion Tityus bahiensis (Buthidae). Toxicon. 39:1009-1019.
50. Possani, L. D., Alagón, A. C., Fletcher, P. L. Jr and Erickson, B. W. 1977. Purification and properties of mammalian toxins from the venom of Brazilian Scorpion Tityus serrulatus Lutz and Mello. Arch Biochem Biophys. 180:394-403.
51. Possani, L. D., Becerril, B., Delepierre, M., and Tytgat, J. 1999. Scorpion toxins specific for Na+-channels. Eur J Biochem. 264:287-300.
52. Possani, L. D., Martin, B. M., Mochca-Morales, J., and Svendsen, I. 1981. Purification and chemical characterization of the major toxins from the venom of the Brasilian scorpion Tityus serrulatus. Carlsberg Res. Commun. 46:195-205.
53. Pucca, M. B., Bertolini, T. B., Barbosa, J. E., Galina, S. V., and Porto, G. S. 2011. Therapeutic monoclonal antibodies: ScFv patents as a marker of a new class of potential biopharma-ceuticals. Braz. J. Pharm. Sci. 47:8.
54. Qiagen. 2003. The QIAexpressionist -A handbook for high-level expression and purification of 6xHis-Tagged proteins. Qiagen, Hilden, Germany.
55. Rates, B., Ferraz, K. K., Borges, M. H., Richardson, M., De Lima, M. E., and Pimenta, A. M. 2008. Tityus serrulatus venom peptidomics: Assessing venom peptide diversity. Toxicon. 52:611-618.
56. Ribeiro, E. L., Pinto, M. C., Labarrère, C. R., Paes, P. R., Paes-Leme, F. O., Chávez-Olórtegui, C., and Melo, M. M. 2010. Biochemical profile of dogs experimentally envenomed with Tityus serrulatus scorpion venom. Toxicon. 55:1125-1131.
57. Rodriguez de la Vega, R. C., and Possani, L. D. 2005. Overview of scorpion toxins specific for Na+ channels and related peptides: Biodiversity, structure-function relationships, and evolution. Toxicon. 46:831-844.
58. Ruhdel, I. W. 2001. Recent developments on the European ban on animal experiments for cosmetics. ALTEX 18:13-16.
59. Sampaio, S. V., Coutinho-Netto, J., Arantes, E. C., Marangoni, S., Oliveira, B., and Giglio, J. R. 1996. Isolation of toxin TsTX-VI from Tityus serrulatus scorpion venom. Effects on the release of neurotransmitters from synaptosomes. Biochem Mol Biol Int. 39:729-740.
60. Sampaio, S. V., Laure, C. J., and Giglio, J. R. 1983. Isolation and characterization of toxic proteins from the venom of the Brazilian scorpion Tityus serrulatus. Toxicon. 21:265-277.
61. Tamarozzi, M. B., Soares, S. G., Marcussi, S., Giglio, J. R., and Barbosa, J. E. 2006. Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom. Biochim Biophys Acta. 1760: 1450-1457.
62. Theakston, R. D., Warrell, D. A., and Griffiths, E. 2003. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon. 41:541-557.
63. Turner, D. J., Ritter, M. A., and George, A. J. 1997. Importance of the linker in expression of single-chain Fv antibody fragments: Optimisation of peptide sequence using phage display technology. J Immunol Methods. 205:43-54.
64. Tuuri, R. E.and Reynolds, S. 2011. Scorpion envenomation and antivenom therapy. Pediatr Emerg Care. 27:667-72; quiz 673.
65. van Noordwijk, A. J., and van Noordwijk, J. 1988. An accurate method for estimating an approximate lethal dose with few animals, tested with a Monte Carlo procedure. Arch Toxicol. 61: 333-343.
66. Whitlow, M., and Filpula, D. 1991. Single-chain Fv proteins and their fusion proteins. Methods. 2:97-105.
67. Zbinden, G., and Flury-Roversi, M. 1981. Significance of the LD50-Test for the toxicological evaluation of chemical substances. Arch Toxicol. 47:77-99.
68. Zoccal, K. F., Bitencourt, C. d. a. S., Secatto, A., Sorgi, C. A., Bordon, K. d. e. C., Sampaio, S. V., Arantes, E. C., and Faccioli, L. H. 2011. Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators. Toxicon. 57: 1101-1108.